原始细胞计数在骨髓增生异常综合征基因亚分类中的相关性。 - Suppr

Suppr

超能文献

Relevance of blast counts for genetic subclassification in MDS.

作者信息

Huber Sandra, Haferlach Torsten, Hutter Stephan, Hoermann Gregor, Kern Wolfgang, Haferlach Claudia

机构信息

MLL Munich Leukemia Laboratory, Max-Lebsche-Platz 31, 81377, Munich, Germany.

出版信息

Leukemia. 2025 Jan;39(1):271-273. doi: 10.1038/s41375-024-02484-4. Epub 2024 Nov 27.

DOI:10.1038/s41375-024-02484-4

PMID:39604619

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11717696/

Abstract

摘要

相似文献

Relevance of blast counts for genetic subclassification in MDS.原始细胞计数在骨髓增生异常综合征基因亚分类中的相关性。

Leukemia. 2025 Jan;39(1):271-273. doi: 10.1038/s41375-024-02484-4. Epub 2024 Nov 27.

Comparison of myeloid blast counts and variant allele frequencies of gene mutations in myelodysplastic syndrome with excess blasts and secondary acute myeloid leukemia.骨髓增生异常综合征伴原始细胞增多和继发性急性髓系白血病中髓系原始细胞计数和基因突变变异等位基因频率的比较。

Leuk Lymphoma. 2021 May;62(5):1226-1233. doi: 10.1080/10428194.2020.1861267. Epub 2020 Dec 19.

A Novel Method to Assess Bone Marrow Purity is Useful in Determining Blast Percentage by Flow Cytometry in Acute Myeloid Leukemia and Myelodysplasia.一种评估骨髓纯度的新方法有助于通过流式细胞术测定急性髓系白血病和骨髓增生异常综合征中的原始细胞百分比。

Ann Hematol Oncol. 2015;2(5).

Proposed changes in the definitions of acute myeloid leukemia and myelodysplastic syndrome: are they helpful?急性髓系白血病和骨髓增生异常综合征定义的拟议更改：它们有帮助吗？

Curr Opin Oncol. 2002 Jan;14(1):19-23. doi: 10.1097/00001622-200201000-00004.

Am J Clin Pathol. 2007 Feb;127(2):197-205. doi: 10.1309/NQ3PMV4U8YV39JWJ.

Blast counts are lower in the aspirate as compared to trephine biopsy in acute myeloid leukemia and myelodysplastic syndrome expressing CD56.在表达 CD56 的急性髓系白血病和骨髓增生异常综合征中，与环钻活检相比，抽吸物中的 blast counts 较低。

Int J Lab Hematol. 2021 Oct;43(5):1078-1084. doi: 10.1111/ijlh.13508. Epub 2021 Mar 11.

Future directions in myelodysplastic syndromes/neoplasms and acute myeloid leukaemia classification: from blast counts to biology.骨髓增生异常综合征/肿瘤及急性髓系白血病分类的未来方向：从原始细胞计数到生物学

Histopathology. 2025 Jan;86(1):158-170. doi: 10.1111/his.15353. Epub 2024 Oct 25.

Expression Levels Combined with Flow Cytometry Blast Counts for Risk Stratification of Acute Myeloid Leukemia and Myelodysplastic Syndromes.结合流式细胞术原始细胞计数的表达水平用于急性髓系白血病和骨髓增生异常综合征的风险分层

Biomedicines. 2021 Apr 6;9(4):387. doi: 10.3390/biomedicines9040387.

Altered responses of purified blast cells from the myelodysplastic syndromes to colony-stimulating factors in vitro: comparison with normal blast cells.骨髓增生异常综合征纯化原始细胞在体外对集落刺激因子的反应改变：与正常原始细胞的比较

Exp Hematol. 1994 Jul;22(7):539-45.

Comparison of blast percentage calculated based on bone marrow all nucleated cells and non-erythroid cells in myelodysplastic syndromes with erythroid hyperplasia.骨髓有核细胞与非红系细胞计算的骨髓增生异常综合征中 blast 百分比的比较。

Ann Hematol. 2019 May;98(5):1127-1133. doi: 10.1007/s00277-018-3560-x. Epub 2018 Nov 24.

引用本文的文献

Validation of clinicopathologic features of a genetic myelodysplastic syndrome classification in an independent cohort.在一个独立队列中对遗传性骨髓增生异常综合征分类的临床病理特征进行验证。

J Hematop. 2025 Sep 12;18(1):42. doi: 10.1007/s12308-025-00658-2.

本文引用的文献

Data-driven, harmonised classification system for myelodysplastic syndromes: a consensus paper from the International Consortium for Myelodysplastic Syndromes.基于数据驱动的骨髓增生异常综合征协调分类系统：国际骨髓增生异常综合征研究协作组共识文件。

Lancet Haematol. 2024 Nov;11(11):e862-e872. doi: 10.1016/S2352-3026(24)00251-5. Epub 2024 Oct 9.

Validation of independent prognostic significance of blast count in a large cohort of MDS patients.在一大群骨髓增生异常综合征（MDS）患者中验证原始细胞计数的独立预后意义。

Leukemia. 2024 Sep;38(9):2064-2067. doi: 10.1038/s41375-024-02348-x. Epub 2024 Jul 16.

Molecular taxonomy of myelodysplastic syndromes and its clinical implications.骨髓增生异常综合征的分子分类及其临床意义。

Blood. 2024 Oct 10;144(15):1617-1632. doi: 10.1182/blood.2023023727.

Molecular patterns identify distinct subclasses of myeloid neoplasia.分子模式可识别髓系肿瘤的不同亚型。

Nat Commun. 2023 May 30;14(1):3136. doi: 10.1038/s41467-023-38515-4.

MDS subclassification-do we still have to count blasts?骨髓增生异常综合征的亚分类——我们仍然需要计算原始细胞吗？

Leukemia. 2023 Apr;37(4):942-945. doi: 10.1038/s41375-023-01855-7. Epub 2023 Feb 22.

International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data.国际髓系肿瘤和急性白血病分类：整合形态学、临床和基因组数据。

Blood. 2022 Sep 15;140(11):1200-1228. doi: 10.1182/blood.2022015850.

The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms.世界卫生组织血液淋巴肿瘤分类第五版：髓系和组织细胞/树突状肿瘤。

Leukemia. 2022 Jul;36(7):1703-1719. doi: 10.1038/s41375-022-01613-1. Epub 2022 Jun 22.

"Blasts" in myeloid neoplasms - how do we define blasts and how do we incorporate them into diagnostic schema moving forward?髓系肿瘤中的“原始细胞”——我们如何定义原始细胞，以及在未来的诊断模式中如何将其纳入？

Leukemia. 2022 Feb;36(2):327-332. doi: 10.1038/s41375-021-01498-6. Epub 2022 Jan 19.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验